| Literature DB >> 31430903 |
Hayato Ishizaka1, Azusa Uematsu2, Yuta Mizushima1, Naohiro Nozawa1, Satoshi Katayanagi1, Kazuhisa Matsumoto1, Kaori Nishikawa1, Reiko Takahashi1, Tomoe Arakawa1, Tatsuya Sawaguchi3, Tomohiro Yasuda4, Suomi Yamaguchi5, Hironaga Ogawa6, Ikuko Shibasaki6, Shigeru Toyoda3, Tibor Hortobágyi7, Hirotsugu Fukuda6, Teruo Inoue3, Takashi Mizushima8, Toshiaki Nakajima3.
Abstract
Blood flow restriction (BFR) has the potential to augment muscle activation, which underlies strengthening and hypertrophic effects of exercise on skeletal muscle. We quantified the effects of BFR on muscle activation in the rectus femoris (RF), the vastus lateralis (VL), and the vastus medialis (VM) in concentric and eccentric contraction phases of low-intensity (10% and 20% of one repetition maximum) leg extension in seven cardiovascular patients who performed leg extension in four conditions: at 10% and 20% intensities with and without BFR. Each condition consisted of three sets of 30 trials with 30 s of rest between sets and 5 min of rest between conditions. Electromyographic activity (EMG) from RF, VL, and VM for 30 repetitions was divided into blocks of 10 trials and averaged for each block in each muscle. At 10% intensity, BFR increased EMG of all muscles across the three blocks in both concentric and eccentric contraction phases. At 20% intensity, EMG activity in response to BFR tended to not to increase further than what it was at 10% intensity. We concluded that very low 10% intensity exercise with BFR may maximize the benefits of BFR on muscle activation and minimize exercise burden on cardiovascular patients.Entities:
Keywords: blood flow restriction; cardiovascular patient; electromyographic activity; leg extension
Year: 2019 PMID: 31430903 PMCID: PMC6723568 DOI: 10.3390/jcm8081252
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Patient characteristics.
| Patient No, Sex | Age (years) | Height (cm) | Weight (kg) | LVEF | Drugs | Diagnosis | Days after Diagnosis |
|---|---|---|---|---|---|---|---|
| No 1, Male | 42 | 168.0 | 57.5 | 66% | ACEI, β-blocker | Post MVP | 482 |
| No 2, Male | 25 | 168.0 | 61.3 | 53% | Post AVR | 105 | |
| No 3, Male | 44 | 172.0 | 77.5 | 52% | ARB, β-blocker | Post AVR, TAP | 482 |
| No 4, Male | 66 | 170.7 | 68.0 | 20% | Post AVR, TAP | 476 | |
| No 5, Male | 70 | 171.4 | 67.5 | 46% | CCB, ACEI, β-blocker | Post BO | 293 |
| No 6, Male | 46 | 170.0 | 67.0 | 63% | Post AVR, TAP | 187 | |
| No 7, Female | 43 | 158.0 | 49.2 | 37% | β-blocker | CHF, MR, AR | 1018 |
LVEF, left ventricular ejection fraction; ACEI, angiotensin converting enzyme inhibitor; β-blocker, β-blocking agents; MVP, mitral valve plasty; AVR, aortic valve replacement; ARB, angiotensin II receptor blocker; TAP, tricuspid annuloplasty; CCB, calcium channels blockers; BO, Bentall operation; CHF, congestive heart failure; MR, mitral regurgitation; AR, aortic regurgitation.
Figure 1Experimental protocol. Upper part depicts the experimental timeline. Middle part details exercise without blood flow restriction (BFR), and lower part details the exercise with BFR.
Electromyographic activity (EMG) activation amplitude during concentric and eccentric contraction phase of leg extension exercise.
| 10% Intensity | 20% Intensity | |||||||
|---|---|---|---|---|---|---|---|---|
| Without BFR | With BFR | Without BFR | With BFR | |||||
| CON | ECC | CON | ECC | CON | ECC | CON | ECC | |
| RF | 10.9 (1.8) | 7.7 (1.0) | 15.4 (2.2) | 12.6 (1.8) | 18.4 (2.5) | 13.5 (1.6) | 19.5 (2.3) | 15.8 (2.0) |
| VL | 15.1 (2.1) | 10.2 (1.1) | 20.3 (2.6) | 15.5 (2.2) | 23.6 (3.2) | 16.5 (2.3) | 25.2 (3.2) | 18.3 (1.9) |
| VM | 12.6 (1.6) | 9.3 (1.3) | 15.6 (2.0) | 12.4 (1.7) | 20.2 (3.0) | 14.3 (2.2) | 20.2 (3.0) | 15.8 (2.3) |
| AVG | 11.8 (2.0) * | 8.5 (1.1) | 16.2 (2.4) * | 12.7 (1.9) | 20.3 (3.2) * | 14.2 (2.1) | 21.6 (3.2) * | 16.6 (2.3) |
Data are mean (±SE) as a percent of maximal voluntary contraction (%MVC); BFR, blood flow restriction; CON, concentric contraction phase; ECC, eccentric contraction phase; RF, rectus femoris; VL, vastus lateralis; VM, vastus medialis; AVG, average EMG value for RF, VL, and VM; *, EMG amplitude is higher during concentric vs. eccentric contraction at same intensity in same BRF condition (all, p < 0.001).
Figure 2Relative EMG activity in the concentric contraction phase. Upper panels: first set; middle panels: second set; lower panels: third set; left panels: data of RF; center panels: data of VL; right panels: data of VM. Filled circle: 10% intensity without BFR; open circle: 10% intensity with BFR; filled square: 20% intensity without BFR; open square: 20% intensity with BFR. * denotes significance (p < 0.05), and # denotes a trend (p < 0.10) of EMG increase by adding BFR at same intensity.
Figure 3Relative EMG activity in the eccentric contraction phase. Upper panels: first set; middle panels: second set; lower panels: third set; left panels: data of RF; center panels: data of VL; right panels: data of VM. Filled circle: 10% intensity without BFR; open circle: 10% intensity with BFR; filled square: 20% intensity without BFR; open square: 20% intensity with BFR. * denotes significance (p < 0.05), and # denotes a trend (p < 0.10) of EMG increase by adding BFR at same intensity.
Ratings of perceived exertion (RPE) after each exercise condition.
| 10% Intensity | 20% Intensity | |||
|---|---|---|---|---|
| Without BFR | With BFR | Without BFR | With BFR | |
| RPE | 10.7 (0.2) | 12.6 (0.5) † | 14.2 (0.4) †† | 15.7 (0.7) ††† |
Data are mean (±SE); RPE, rate of perceived exertion; BFR, blood flow restriction; †, RPE is higher with BFR vs. without BFR at 10% intensity (p < 0.001); ††, RPE is higher without BFR at 10% intensity vs. with BFR at 10% intensity (p < 0.001); †††, RPE is higher with BFR vs. without BFR at 20% intensity (p < 0.001).